There are numerous polymers that have been used commercially to produce pharmaceutical solid dispersions and solutions from hot melt extrusion. Affinisol™ (HPMC) and Plasdone™ S630 (PVP based co-povidone copolymer) have been used in the present work to determine the viable processing space with regards thermal and work input on a twin screw extruder. Processing viability has been determined by monitoring degradation, initially assessed by physical appearance and colour of the extrudates across the full operating range of a twin screw extruder. It has been found that the Affinisol™ had a relatively narrow viable operating window compared with the Plasdone™
3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers has gained ...
Over the past few decades hot melt extrusion (HME) has emerged as a powerful processing technology f...
Fused Deposition Modelling (FDM) is one of the most widely used Additive Manufacturing (AM) technolo...
There are numerous polymers that have been used commercially to produce pharmaceutical solid dispers...
The aim of this work is to: (1) Determine the viable processing window of HPMC-Affinisol polymer to ...
The aim of the present work was to develop a pilot scale process to produce drug-loaded filaments fo...
Linking a hot-melt-extrusion (HME) process to 3D printing offers the ability for rapid prototyping o...
Three-dimensional printing, also known as additive manufacturing, is a fabrication process whereby a...
Three-dimensional printing, also known as additive manufacturing, is a fabrication process whereby a...
Twin-screw extruders are being increasingly applied in the pharmaceutical industry for the manufactu...
Coupling hot-melt extrusion (HME) with fused deposition modeling (FDM) three-dimensional printing (3...
In recent years, the demand for developing patient-centric dosage forms is increasing enormously wit...
Three-dimensional (3D) printing technology enables the design of new drug delivery systems for perso...
Three-dimensional printing (3DP) provides a flexible and cost-beneficial solution to patient-centric...
Fused deposition modeling (FDM) 3D printing was used to produce 3D printed tablets with the thermo-s...
3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers has gained ...
Over the past few decades hot melt extrusion (HME) has emerged as a powerful processing technology f...
Fused Deposition Modelling (FDM) is one of the most widely used Additive Manufacturing (AM) technolo...
There are numerous polymers that have been used commercially to produce pharmaceutical solid dispers...
The aim of this work is to: (1) Determine the viable processing window of HPMC-Affinisol polymer to ...
The aim of the present work was to develop a pilot scale process to produce drug-loaded filaments fo...
Linking a hot-melt-extrusion (HME) process to 3D printing offers the ability for rapid prototyping o...
Three-dimensional printing, also known as additive manufacturing, is a fabrication process whereby a...
Three-dimensional printing, also known as additive manufacturing, is a fabrication process whereby a...
Twin-screw extruders are being increasingly applied in the pharmaceutical industry for the manufactu...
Coupling hot-melt extrusion (HME) with fused deposition modeling (FDM) three-dimensional printing (3...
In recent years, the demand for developing patient-centric dosage forms is increasing enormously wit...
Three-dimensional (3D) printing technology enables the design of new drug delivery systems for perso...
Three-dimensional printing (3DP) provides a flexible and cost-beneficial solution to patient-centric...
Fused deposition modeling (FDM) 3D printing was used to produce 3D printed tablets with the thermo-s...
3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers has gained ...
Over the past few decades hot melt extrusion (HME) has emerged as a powerful processing technology f...
Fused Deposition Modelling (FDM) is one of the most widely used Additive Manufacturing (AM) technolo...